Stonegate Investment Group, LLC Mannkind Corp Transaction History
Stonegate Investment Group, LLC
- $3.67 Billion
- Q3 2024
A detailed history of Stonegate Investment Group, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Stonegate Investment Group, LLC holds 18,500 shares of MNKD stock, worth $111,185. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,500
Previous 18,500
-0.0%
Holding current value
$111,185
Previous $96,000
20.83%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding MNKD
# of Institutions
243Shares Held
148MCall Options Held
1.62MPut Options Held
802K-
Black Rock Inc. New York, NY22.6MShares$136 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.6MShares$94 Million0.0% of portfolio
-
State Street Corp Boston, MA9.6MShares$57.7 Million0.0% of portfolio
-
Nitorum Capital, L.P. New York, NY9.16MShares$55 Million6.38% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.75MShares$52.6 Million0.83% of portfolio
About MANNKIND CORP
- Ticker MNKD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 257,338,000
- Market Cap $1.55B
- Description
- MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...